Category: CLSI
CLSI
Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline–Second Edition (Interim Revision), EP09A2IR
standard by Clinical and Laboratory Standards Institute, 07/01/2010
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
standard by Clinical and Laboratory Standards Institute, 04/25/2016
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 3rd Edition
standard by Clinical and Laboratory Standards Institute, 06/01/2015
User Verification of Performance for Precision and Trueness; Approved Guideline – Third Edition, EP15A3E
standard by Clinical and Laboratory Standards Institute, 09/01/2014
Procedures for the Recovery and Identification of Parasites From the Intestinal Tract; Approved Guideline, M28A2E
standard by Clinical and Laboratory Standards Institute, 06/30/2005
Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E Antibodies of Defined Allergen Specificities, 3rd Edition, ILA20Ed3E
standard by Clinical and Laboratory Standards Institute, 10/01/2016
Laboratory Design; Approved Guideline – Second Edition, QMS04Ed3E
standard by Clinical and Laboratory Standards Institute, 06/01/2016
Training and Competence Assessment; Approved Guideline–Fourth Edition; QMS03Ed4E
standard by Clinical and Laboratory Standards Institute, 12/01/2016
User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline, Second Edition, EP122A
standard by Clinical and Laboratory Standards Institute, 01/01/2008
